Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001225208-13-022426)

Filing Details

Accession Number:
0001225208-13-022426
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-29 19:11:04
Reporting Period:
2013-10-28
Filing Date:
2013-10-29
Accepted Time:
2013-10-29 19:11:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204528 L Herbert Henkel C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-10-28 1,200 $57.01 10,901 No 4 M Direct
Common Stock Acquisiton 2013-10-28 1,200 $54.97 12,101 No 4 M Direct
Common Stock Disposition 2013-10-28 2,400 $134.66 9,701 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (Right to Buy) Disposition 2013-10-28 1,200 $0.00 1,200 $54.97
Common Stock Option (Right to Buy) Disposition 2013-10-28 1,200 $0.00 1,200 $57.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-07-14 No 4 M Direct
0 2014-09-08 No 4 M Direct
Footnotes
  1. Includes 36.0917 shares acquired under the Company's Dividend Reinvestment Plan from February 8, 2013 to October 28, 2013.
  2. Represents the weighted average sales price for price increments ranging from $134.585 to $134.77. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
  3. Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated (formerly known as the 1988 Directors' Stock Award Plan).
  4. Options vested in three equal annual installments beginning on July 14, 2005 and are currently exercisable.
  5. Options vested in three equal annual installments beginning on September 8, 2005 and are currently exercisable.